| 2205 |
1821: Decrease, Cell proliferation |
1521: Decrease, Growth |
Nov 12, 2020 |
Jul 6, 2022 |
9 AOPs
|
| 2405 |
1821: Decrease, Cell proliferation |
1878: Decreased, Eye size |
May 28, 2021 |
Aug 7, 2021 |
1 AOP
|
| 2724 |
1821: Decrease, Cell proliferation |
2041: Decrease, facial prominence outgrowth |
Jul 28, 2022 |
Apr 2, 2025 |
2 AOPs
|
| 3586 |
1821: Decrease, Cell proliferation |
2348: Inhibition, Liver regeneration |
Aug 16, 2025 |
Aug 16, 2025 |
1 AOP
|
| 2755 |
2060: Decrease, Chitin laminar organization |
2062: Weak, Procuticle protection |
Aug 28, 2022 |
Aug 28, 2022 |
1 AOP
|
| 1665 |
1473: Decrease, Chlorophyll synthesis |
1474: Decrease, Light harvest capacity |
Oct 10, 2017 |
Oct 10, 2017 |
1 AOP
|
| 1347 |
1266: Decrease, Circulating CCAP |
1267: Decrease, Ecdysis motor program activity |
Feb 9, 2017 |
Feb 9, 2017 |
3 AOPs
|
| 1000 |
988: Decrease, Circulating ETH |
990: Increase, Incomplete ecdysis |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1008 |
988: Decrease, Circulating ETH |
993: Decrease, Abdominal muscle contraction |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1346 |
988: Decrease, Circulating ETH |
1266: Decrease, Circulating CCAP |
Feb 9, 2017 |
Feb 9, 2017 |
3 AOPs
|
| 2126 |
1690: Decrease, circulating testosterone levels |
1613: Decrease, DHT level |
May 11, 2020 |
Oct 19, 2023 |
1 AOP
|
| 2131 |
1690: Decrease, circulating testosterone levels |
1614: Decrease, AR activation |
May 11, 2020 |
Apr 5, 2024 |
4 AOPs
|
| 3169 |
1690: Decrease, circulating testosterone levels |
2212: Epididymal agenesis |
Mar 20, 2024 |
Dec 3, 2024 |
1 AOP
|
| 3202 |
1690: Decrease, circulating testosterone levels |
809: malformed, Male reproductive tract |
Apr 25, 2024 |
Apr 25, 2024 |
1 AOP
|
| 3205 |
1690: Decrease, circulating testosterone levels |
348: Malformation, Male reproductive tract |
May 1, 2024 |
May 1, 2024 |
1 AOP
|
| 3206 |
1690: Decrease, circulating testosterone levels |
414: Increase, Luteinizing hormone (LH) |
May 1, 2024 |
May 1, 2024 |
1 AOP
|
| 3213 |
1690: Decrease, circulating testosterone levels |
219: Reduction, Plasma 17beta-estradiol concentrations |
May 8, 2024 |
May 8, 2024 |
1 AOP
|
| 3214 |
1690: Decrease, circulating testosterone levels |
2139: Reduction, the ratio of E2/11-KT in plasma |
May 8, 2024 |
May 8, 2024 |
1 AOP
|
| 3225 |
1690: Decrease, circulating testosterone levels |
520: Decreased sperm quantity or quality in the adult, Decreased fertility |
May 24, 2024 |
May 24, 2024 |
1 AOP
|
| 3227 |
1690: Decrease, circulating testosterone levels |
791: Increased, Leutinizing hormone (LH) |
May 24, 2024 |
May 24, 2024 |
1 AOP
|
| 3349 |
1690: Decrease, circulating testosterone levels |
1688: AGD, decreased |
Oct 1, 2024 |
May 6, 2025 |
1 AOP
|
| 3350 |
1690: Decrease, circulating testosterone levels |
2082: Hypospadias |
Oct 1, 2024 |
Sep 18, 2025 |
1 AOP
|
| 3486 |
1690: Decrease, circulating testosterone levels |
1786: nipple retention, increased |
Jan 30, 2025 |
Sep 17, 2025 |
1 AOP
|
| 3620 |
1690: Decrease, circulating testosterone levels |
1758: Impaired, Spermatogenesis |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 1600 |
1446: Decrease, Coupling of OXPHOS |
40: Decrease, Mitochondrial ATP production |
Jun 29, 2017 |
Jun 29, 2017 |
None
|